Dr. Salah Eldin Allam is a seasoned pharmaceutical regulatory expert with over 18 years of experience in drug inspection, market surveillance, and regulatory compliance. As the Manager of Pharmacy and Warehouse Inspection at the Egyptian Drug Authority (EDA), he leads strategic initiatives to combat substandard and falsified medical products (SFMPs), oversees nationwide inspections, and develops regulatory frameworks aligned with WHO standards.

Key Achievements:

• Regulatory Leadership: Spearheaded Egypt’s achievement of WHO Maturity Level 3 (for vaccines and pharmaceuticals) as the focal point for market control and inspections.

• Global Collaboration: Serves as Egypt’s focal point for the WHO Global Surveillance and Monitoring System (GSMS) and actively contributes to WHO guidelines on SFMP prevention.

• Capacity Building: Trained 400+ inspectors and international counterparts (e.g., Libyan NRA) on post-market surveillance (PMS) and Good Distribution Practices (GDP).

• Policy Development: Authored Egypt’s risk-based sampling guidelines, GSDP standards, and SOPs for PMS, enhancing regulatory oversight.

• Digital Transformation: Pioneered track-and-trace systems and digital tools for market surveillance in Egypt.

Education & Training:

• Bachelor of Pharmacy, Ain Shams University (2005)

• Certified in WHO Global Benchmarking Tool (GBT), ISO 9001:2015, Supply Chain Security, and Cold Chain Management.

Recent Engagements:

• Member, WHO Member State Mechanism on SFMPs (Working Group on Regulatory Capacity).

• Contributor, AUDA-NEPAD subcommittee on market surveillance (Africa-wide guidelines).